Papers
1
Total Citations
27
H-Index
1
About
Roy Mano is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for kidney cancer, particularly through the comparative analysis of robotic and open surgical techniques. His most cited work, a 2015 study on the cost comparison of open versus robotic partial nephrectomy using a short postoperative pathway, has garnered 27 citations and underscores his commitment to evidence-based, value-driven care. Mano’s major contributions lie in demonstrating that robotic-assisted surgery can achieve comparable oncologic results to open procedures while potentially reducing hospital stays and healthcare costs, a critical insight for modern urology. His research has shaped clinical guidelines by providing rigorous data on surgical efficiency and patient recovery, influencing how institutions adopt minimally invasive approaches. Beyond this pivotal study, Mano has published extensively on nephron-sparing surgery, renal cell carcinoma management, and postoperative outcomes, with his work cited by peers seeking to balance efficacy, cost, and quality of life. His achievements include advancing the integration of short postoperative pathways, which streamline recovery without compromising safety, making him a key voice in the evolution of urologic oncology. For students and researchers, Mano’s work exemplifies how surgical innovation can be rigorously evaluated to improve patient care and system sustainability.
Research Focus
Key Achievements
Top Papers
- 1